Identifying effect modifiers of systemic hydrocortisone treatment initiated 7-14 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial.
Halbmeijer NM, Sonnaert M, Swarte RM, Koopman-Esseboom C, van Stuijvenberg M, Mulder-de Tollenaer S, Tan RNGB, Mohns T, Bruneel E, Steiner K, Kramer BW, Debeer A, van Weissenbruch MM, Marechal Y, Blom H, Plaskie K, Offringa M, Merkus MP, Onland W, Leemhuis AG, van Kaam AH; SToP-BPD Study group.
Halbmeijer NM, et al. Among authors: debeer a.
Arch Dis Child Fetal Neonatal Ed. 2024 Feb 19;109(2):159-165. doi: 10.1136/archdischild-2023-325558.
Arch Dis Child Fetal Neonatal Ed. 2024.
PMID: 37722765
Clinical Trial.